Shankar B. Patil

Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

Paul A. Gurbel, Kevin P. Bliden, Kathleen Butler et al. · Circulation · 2009 · 1.1K citations

Medicine, Pharmacology, Pharmacotherapy +17

Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes

Robert F. Storey, Dominick J. Angiolillo, Shankar B. Patil et al. · Journal of the American College of Cardiology · 2010 · 368 citations

Medicine, Pharmacology, Pharmacotherapy +16

Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study

Robert F. Storey, Kevin P. Bliden, Shankar B. Patil et al. · Journal of the American College of Cardiology · 2010 · 185 citations

Medicine, Cardiology, Pharmacotherapy +14

Ticagrelor Effectively and Reversibly Blocks Murine Platelet P2Y ₁₂ -Mediated Thrombosis and Demonstrates a Requirement for Sustained P2Y ₁₂ Inhibition to Prevent Subsequent Neointima

Shankar B. Patil, Laura E. Jackman, Sheila Francis et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 50 citations

Medicine, Pharmacology, Pharmacotherapy +17

Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel

Heather M. Judge, Shankar B. Patil, Robert Buckland et al. · Journal of Thrombosis and Haemostasis · 2010 · 44 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17